No reason except for a valuable investment lesson I have

New Post Public Reply Private Reply Replies (1) Message Board
docj tc2000chartreader #14946
375
No reason except for a valuable investment lesson I have been taught several times by Generex. When you have a huge gain, take some profit. I have literally "lost" a fortune on paper being a long term holder in Generex having ridden this up and down at least 3 times. Made some nice cash along the way but always had a large core holding. It turns out this stock is best used as a vehicle for day trading. As bad as not realizing the gain I coulda shoulda woulda had, I have lost out on the investment of a lifetime in Cytodyn.


I only sold 15% today of my CYDY core position plus I did a day trade in my son's college fund account. The data is incredible. The funny thing is the CV-19 treatment indication is small potatoes compared to cancer for them. Plus HIV and 10-12 other indications including a huge one in NASH which is huge.

NGIO where is our vaccine progress? Leronlimab can help fewer people die but it can't stop CV-19 from infecting us!

SEC where is Generex's S-1 approval?

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Yoshiharu Global's Stock Struggles Amid Market Fluctuations

Updated Category News Views 101

Yoshiharu Global Stock Faces Major Challenges Yoshiharu Global Co. is currently navigating through turbulent waters, as evidenced by the stock reaching a concerning 52-week low of $2.7. This decline starkly contrasts its previous performance, revealing a significant drop of 43.1% in value over the past year. Investors are reflecting on the broader market conditions and...

Continue Reading
Investors Alert: Class Action Against Nextracker Inc. Uncovered

Updated Category News Views 172

Class Action Lawsuit Filed Against Nextracker Inc. Investors are being informed about a recent class action lawsuit that has been initiated concerning Nextracker Inc. (NASDAQ: NXT). This case was filed on behalf of all individuals and entities who acquired shares of Nextracker’s common stock during a specified period. Nextracker, known for its innovative solar...

Continue Reading
Boba Mint Holdings Reports Significant Growth for Tanjea Game

Updated Category News Views 74

Boba Mint Holdings Celebrates Impressive Milestones in Gaming Boba Mint Holdings Ltd. (CSE: TNJ) recently announced outstanding milestones in user growth for its flagship blockchain mobile game, Tanjea. Following the last update on user downloads back in May, the company has reported that total downloads for Tanjea have now exceeded 409,670, with an impressive count of...

Continue Reading
Tixel i® Revolutionizes Dry Eye Treatment with Strong Results

Updated Category News Views 265

Tixel i® Revolutionizes Dry Eye Treatment A recent publication highlights the remarkable advancements Tixel i® has brought to the field of ophthalmology, particularly for patients dealing with Evaporative Dry Eye Disease (DED) linked to Meibomian Gland Dysfunction (MGD). This cutting-edge technology has gained recognition for its effectiveness in providing long-lasting...

Continue Reading
ClarityPay Enhances Leadership with MJ Panda as COO for Growth

Updated Category News Views 141

ClarityPay Enhances Leadership with MJ Panda as COO ClarityPay, a frontrunner in customized point-of-sale credit solutions, has appointed Mrutyunjaya "MJ" Panda as its new Chief Operating Officer. Panda brings with him an impressive background, having held significant roles at both Goldman Sachs and American Express, where he developed a wealth of knowledge in risk...

Continue Reading